|
業務類別
|
Biotechnology |
|
業務概覽
|
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease. |
| 公司地址
| 171 Oyster Point Boulevard, Suite 500, 5th Floor, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 825-6990 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.tenayatherapeutics.com |
| 員工數量
| 70 |
| Mr. Faraz Ali, M.B.A. |
Director, Chief Executive Officer and Interim Principal Financial Officer |
美元 664.17K |
16/04/2026 |
| Mr. Tomohiro Higa, M.B.A. |
Senior Vice President, Finance and Interim Principal Accounting Officer |
-- |
11/03/2026 |
| Dr. Whittemore Tingley, M.D.,PhD |
Chief Medical Officer |
美元 521.19K |
16/04/2026 |
|
|
| Dr. Robert Sanders Williams, M.D. |
Non-Executive Chairman of The Board |
16/04/2026 |
| Mr. Jeffrey T. Walsh, M.B.A. |
Independent Director |
16/04/2026 |
| Mr. Faraz Ali, M.B.A. |
Director, Chief Executive Officer and Interim Principal Financial Officer |
16/04/2026 |
| Ms. Amy Burroughs, M.B.A. |
Independent Director |
16/04/2026 |
| Ms. Karah Parschauer, J.D. |
Independent Director |
16/04/2026 |
| Dr. June Lee, M.D. |
Independent Director |
16/04/2026 |
| Dr. Catherine Stehman-Breen, M.D. |
Independent Director |
16/04/2026 |
| Dr. Deepak Srivastava, M.D. |
Independent Director |
16/04/2026 |
|
|
|
|
